CD8+ Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4+ Tregs in mice
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD8+ Tregs promote GVHD prevention and overcome the impaired GVL effect mediated by CD4+ Tregs in mice
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 6, Pages e1146842
Publisher
Informa UK Limited
Online
2016-03-29
DOI
10.1080/2162402x.2016.1146842
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease
- (2015) Jun Li et al. JOURNAL OF IMMUNOLOGY
- Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
- (2014) Jianing Fu et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Induced regulatory T-cells (iTregs) generated by activation with anti-CD3/CD28 antibodies differ from those generated by the physiological-like activation with antigen/APC
- (2014) Chan Zhao et al. CELLULAR IMMUNOLOGY
- Pharmacologic inhibition of PKC and PKC prevents GVHD while preserving GVL activity in mice
- (2013) K. M. K. Haarberg et al. BLOOD
- Induced Regulatory T Cells Promote Tolerance When Stabilized by Rapamycin and IL-2 In Vivo
- (2013) P. Zhang et al. JOURNAL OF IMMUNOLOGY
- Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies
- (2013) Xu-chao Zhang et al. Journal of Translational Medicine
- Identification and expansion of highly suppressive CD8+FoxP3+ regulatory T cells after experimental allogeneic bone marrow transplantation
- (2012) R. J. Robb et al. BLOOD
- CD8+ Foxp3+ Regulatory T Cells Are Induced during Graft-versus-Host Disease and Mitigate Disease Severity
- (2012) A. J. Beres et al. JOURNAL OF IMMUNOLOGY
- A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells
- (2012) Wenxian Fu et al. NATURE IMMUNOLOGY
- Generation and Large-Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft-Versus-Host Disease
- (2011) K. L. Hippen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficient and Selective Prevention of GVHD by Antigen-Specific Induced Tregs via Linked-Suppression in Mice
- (2011) Kenrick Semple et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and ROR t in mice
- (2011) Y. Yu et al. BLOOD
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
- (2011) M. Di Ianni et al. BLOOD
- Instability of Foxp3 Expression Limits the Ability of Induced Regulatory T Cells to Mitigate Graft versus Host Disease
- (2011) A. Beres et al. CLINICAL CANCER RESEARCH
- Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice
- (2011) Uri Sela et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity
- (2011) K. L. Hippen et al. Science Translational Medicine
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
- (2009) Piotr Trzonkowski et al. CLINICAL IMMUNOLOGY
- Alloantigen-specificde novo-induced Foxp3+Treg revertin vivoand do not protect from experimental GVHD
- (2009) Christian Koenecke et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- 2 integrins separate graft-versus-host disease and graft-versus-leukemia effects
- (2007) Y. Liang et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now